Comparative evaluation of nasopharyngeal swab and saliva specimens for the molecular detection of SARS-CoV-2 RNA in Japanese patients with COVID-19

Published:September 29, 2020DOI:https://doi.org/10.1016/j.jiac.2020.09.027

      Abstract

      Considering the issues of shortage of medical resources and the invasiveness and infection risk involved in the collection of nasopharyngeal swab specimens, there is a need for an effective alternative test specimen for SARS-CoV-2 RNA detection. Here, we investigated suitability of saliva as a non-invasively obtained specimen for molecular detection of SARS-CoV-2 RNA in Japanese patients with COVID-19. In total, 28 paired clinical specimens of saliva and nasopharyngeal swabs were collected from 12 patients at various time points after symptom onset. Each specimen was assayed using reverse transcription real-time polymerase chain reaction (rRT-PCR) on the BD MAX open system using primers and probes targeting the N-gene. The saliva and nasopharyngeal swab specimens showed 19 and 15 positive results, respectively. No invalid (PCR inhibition) result was observed for any specimen. The qualitative results of each specimen obtained in the period immediately after symptom onset were similar. Three convalescent patients presented saliva-positive results, whereas their nasopharyngeal swabs were negative at four different time points, suggesting that saliva may be superior to nasopharyngeal swabs in terms of obtaining stable assay result of SARS-CoV-2. In conclusion, our results suggest that saliva can potentially serve as an alternative to nasopharyngeal swabs as a specimen for SARS-CoV-2 rRT-PCR. As saliva can be collected by patients themselves, it may be an effective way to overcome the shortage of personal protective equipment and specimen sampling tools.

      Keywords

      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to Journal of Infection and Chemotherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ministry of Health, Labour and Welfare Japan
        About coronavirus disease.
        • National Institute of Infectious Diseases Japan
        nCoV (new coronavirus) Sample collection and transportation manual.
        (ver. 16 April 2020)
        • Khurshid Z.
        • Asiri F.Y.I.
        • Al Wadaani H.
        Human saliva: non-invasive fluid for detecting novel coronavirus (2019-nCoV).
        Int J Environ Res Publ Health. 2020; 17E2225https://doi.org/10.3390/ijerph17072225
        • Golatowski C.
        • Salazar M.G.
        • Dhople V.M.
        • Hammer E.
        • Kocher T.
        • Jehmlich N.
        • et al.
        Comparative evaluation of saliva collection methods for proteome analysis.
        Clin Chim Acta. 2013; 419: 42-46https://doi.org/10.1016/j.cca.2013.01.013
        • Shirato K.
        • Nao N.
        • Katano H.
        • Takayama I.
        • Saito S.
        • Kato F.
        • et al.
        Development of genetic diagnostic methods for novel coronavirus 2019 (nCoV-2019) in Japan.
        Jpn J Infect Dis. 2020; https://doi.org/10.7883/yoken.JJID.2020.061
        • Zou L.
        • Ruan F.
        • Huang M.
        • Liang L.
        • Huang H.
        • Hong Z.
        • et al.
        SARS-CoV-2 viral load in upper respiratory specimens of infected patients.
        N Engl J Med. 2020; 382: 1177-1179https://doi.org/10.1056/NEJMc2001737
        • Azzi L.
        • Carcano G.
        • Gianfagna F.
        • Grossi P.
        • Gasperina D.D.
        • Genoni A.
        • et al.
        Saliva is a reliable tool to detect SARS-CoV-2.
        J Infect. 2020; S0163–4453: 30213-30219https://doi.org/10.1016/j.jinf.2020.04.005
        • To K.K.
        • Tsang O.T.
        • Chik-Yan Yip C.
        • Chan K.H.
        • Wu T.C.
        • Chan J.M.C.
        • et al.
        Consistent detection of 2019 novel coronavirus in saliva.
        Clin Infect Dis. 2020; 12 (ciaa149)https://doi.org/10.1093/cid/ciaa149
        • Iwasaki S.
        • Fujisawa S.
        • Nakakubo S.
        • Kamada K.
        • Yamashita Y.
        • Fukumoto T.
        • et al.
        Comparison of SARS-CoV-2 detection in nasopharyngeal swab and saliva.
        J Infect. 2020; 81: e145-e147https://doi.org/10.1016/j.jinf.2020.05.071
        • Williams E.
        • Bond K.
        • Zhang B.
        • Putland M.
        • Williamson D.A.
        Saliva as a non-invasive specimen for detection of SARS-CoV-2.
        J Clin Microbiol. 2020; (JCM.00776-20)https://doi.org/10.1128/JCM.00776-20
        • Jamal A.J.
        • Mohammad M.
        • Coomes E.
        • Powis J.
        • Li A.
        • Paterson A.
        • et al.
        Sensitivity of nasopharyngeal swabs and saliva for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
        medRxiv. 2020; https://doi.org/10.1101/2020.05.01.20081026
        • Bellagambi F.G.
        • Lomonaco T.
        • Salvo P.
        • Vivaldi F.
        • Hangouët M.
        • Ghimenti S.
        • et al.
        Saliva sampling: methods and devices. An overview.
        Trends Anal Chem. 2020; 124: 115781https://doi.org/10.1016/j.trac.2019.115781